Charles River Speakers

Alan Smith

Executive Director, Global Scientific Portfolio Management, Cell and Gene Therapy I CDMO · Charles River Laboratories

5 events

cell and gene therapyCDMOscientific portfolio management

Susanne Bäck

Charles River

3 events

ALS drug discoverydisease modelinggene therapies

Samuel Chuang

3 events

new approach methodologiesdrug discoveryneuroscience innovation

Malika Bsibsi

Research Leader · Charles River Laboratories

3 events

hiPSC-derived microglianeuroinflammationdrug discovery

Kirsten Dolph

Senior Vice President of Global Manufacturing · Charles River Laboratories

2 events

cell and gene therapybiotech incubatorCDMO services

Matthew Hewitt

Vice President, CTO Manufacturing Business Division · Charles River Laboratories

2 events

biotech fundingresearch developmentinvestment

Dr Rob Howes

Senior Director · Charles River Laboratories

1 event

contract research organisationssustainabilitycommunity engagement

Charles River Laboratories

1 event

Matthew M Hewitt

Charles River Laboratories

1 event

biotechlaboratory research

Steven Bulera, PhD, DABT

Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment · Charles River Laboratories

1 event

preclinical developmentanimal testing alternativesR&D funding

Steven Bulera

Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment · Charles River Laboratories

1 event

preclinical developmentdrug discoveryregulatory challenges

Matthew Hewitt, PhD

Vice President, CTO Manufacturing Business Division · Charles River Laboratories

1 event

federal fundingresearch fundingbiotech investment

Charles River Laboratories Ltd. - RIFM

Charles River Laboratories Ltd.

1 event

Charles River Laboratories - RIFM

Charles River Laboratories

1 event

Charles River speakers